5971 - 5980 of 7942 Results
Title
Year
- D-512, a novel dopamine D2/3receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats2017OPENTitle: D-512, a novel dopamine D2/3receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian ratsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 174Issue #: 18Start Page: 3058End Page: 3071Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.13937Best OA location URL: https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.13937Citation Count: 22
- Deregulation of α-synuclein in Parkinson’s disease: Insight from epigenetic structure and transcriptional regulation of SNCA2017RESTRICTEDTitle: Deregulation of α-synuclein in Parkinson’s disease: Insight from epigenetic structure and transcriptional regulation of SNCAJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 154Issue #:Start Page: 21End Page: 36Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pneurobio.2017.04.004Best OA location URL: https://europepmc.org/articles/pmc5557282?pdf=renderCitation Count: 56
-
RESTRICTEDTitle: Improved Neuroimaging Atlas of the Dentate NucleusJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 16Issue #: 5-6Start Page: 951End Page: 956Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12311-017-0872-7Citation Count: 21
-
RESTRICTEDTitle: Parkin and PINK1 functions in oxidative stress and neurodegenerationJournal Name: Brain Research BulletinPublisher: Elsevier BVVol: 133Issue #:Start Page: 51End Page: 59Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainresbull.2016.12.004Best OA location URL: https://europepmc.org/articles/pmc5718625?pdf=renderCitation Count: 120
-
OPENTitle: Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's diseaseJournal Name: Toxicology and Applied PharmacologyPublisher: Elsevier BVVol: 326Issue #:Start Page: 34End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.taap.2017.04.004Best OA location URL: https://europepmc.org/articles/pmc5704913?pdf=renderCitation Count: 12
-
RESTRICTEDTitle: Suspected non-Alzheimer's pathology – Is it non-Alzheimer's or non-amyloid?Journal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 36Issue #:Start Page: 20End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2017.02.003Citation Count: 33
- Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings2017OPENTitle: Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling SettingsJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 26Issue #: 6Start Page: 1165End Page: 1172Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0123-6Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1007/s10897-017-0123-6Citation Count: 9
- Multiple reaction monitoring (MRM)‐profiling for biomarker discovery applied to human polycystic ovarian syndrome2017RESTRICTEDTitle: Multiple reaction monitoring (MRM)‐profiling for biomarker discovery applied to human polycystic ovarian syndromeJournal Name: Rapid Communications in Mass SpectrometryPublisher: WileyVol: 31Issue #: 17Start Page: 1462End Page: 1470Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/rcm.7927Citation Count: 33
- Quantitative proteomics identifies altered O‐GlcNAcylation of structural, synaptic and memory‐associated proteins in Alzheimer's disease2017OPENTitle: Quantitative proteomics identifies altered O‐GlcNAcylation of structural, synaptic and memory‐associated proteins in Alzheimer's diseaseJournal Name: The Journal of PathologyPublisher: WileyVol: 243Issue #: 1Start Page: 78End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/path.4929Best OA location URL: https://europepmc.org/articles/pmc5647145?pdf=renderCitation Count: 111
- The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease2017OPENTitle: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0456-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0456-2Citation Count: 80